expression had occurred in these cells. It should be stressed that, after up to 100 additional passages, cells cultured in the absence of interferon maintained their nontumorigenic character in spite of the persistent transcription of the mos oncogene.
Moloney murine sarcoma virus (MoMuSV), a replicationdefective retrovirus that transforms fibroblasts in tissue culture and induces fibrosarcomas in vivo, arose by recombination of the nondefective Moloney murine leukemia virus (MuLV) and cellular sequences present within the normal BALB/c genome (1) (2) (3) . The latter sequences, designated y-mos, are essential for the virus-induced transformation (3) (4) (5) . The homologous cellular DNA sequences are termed c-mos.
When sensitive cells are treated with interferon (IFN) prior to infection with retroviruses, the integration of the viral genome into cellular DNA is inhibited (6) (7) (8) . After integration, the viral expression can still be reversibly modified by short-term treatments with IFN (9-13). Entirely different results were obtained in BALB/c fibroblasts productively transformed with MoMuSV and, thereafter, cultivated for long periods (over 200 passages) in the presence of low concentrations of IFN. The resulting new cellular population was termed murine sarcoma virus-transformed, IFN-treated (MSVIF') and displayed orderly growth and flat morphology as well as lack of colony formation in agar (14) . The morphological reversion observed in MSVIF+ cells could be related, at least in part, to the reconstitution of the degraded cytoskeleton (15) as well as to the neosynthesis of a dense but faulty extracellular matrix consisting of fibronectin and collagen (16) . Moreover, MSVIF+ cells were resistant to exogenous IFN when assayed with cytolytic indicator viruses (14) . Thus we decided to explore the new cell-virus relationship resulting from the long-term IFN treatment, as well as the presence and expression of the v-mos gene.
MATERIALS AND METHODS
Cells and Viruses. The following continuous mouse cell lines were used: NIH 3T3 (17) clone CBB, BALB/3T3 (18), 3T3FL (19) , FG10 (S'L-) (20) , as well as the XC-transformed rat cell line (21) . The MSV.B line, obtained by transformation of embryonic BALB/c fibroblasts with MoMuSV (original virus stock) (14, 22) , was passaged in parallel with the IFN-treated cells as an MoMuSV-transformed cell control. The MSVIF+ line was derived from these cells by culturing them in medium containing IFN (50 units/ml) for over 200 passages (14) . Two sublines were also used: MSVIFa (cultured for 280 passages in the presence of IFN Southern (30) . Prehybridization, hybridization, and washing procedures were as described by Thomas (31) . Autoradiography was performed with Kodak SB 5 film and an intensifying screen at -80'C.
RNA Preparation and Analysis. Total cell RNA was prepared by the urea/LiCl method (32) . Polyadenylylated RNA was isolated from total RNA by affinity chromatography on oligo(dT)-cellulose (33) . Poly(A)+ RNA samples (5 ,g) were denatured by the glyoxal method (34) and electrophoresed in 1% agarose gels at 6 V/cm. RNA was transferred to nitrocellulose filters, and hybridization and autoradiography were performed as for DNA analysis (31) .
Virion RNA Analysis. Virus was harvested at 3-hr intervals from the fluids of 48-to 72-hr-old MSVIFa and MSV.B cell cultures precipitated with ammonium sulfate to 50% saturation (at + 40C), and pelleted at 10,000 x g for 1 hr. Viral RNA was prepared, gradient-purified (35) , and further processed for transfer and hybridization as described for cellular RNA.
DNA Probes. The v-mos sequences used as probes were derived from cloned proviral ml-MoMuSV DNA (36, 37 transformed foci could be observed after 14-21 days ( Table  2) . The foci were similar in number and shape to those detected in NIH 3T3 cells transfected with MT cell DNA, while no foci were formed by control cells transfected with BALB/3T3 DNA. The foci generated by transfection with MSVIFa DNA were not rescued upon superinfection with helper virus, since no transforming virus particles emerged In EcoRI digests of DNA extracted from control MoMu-SV-transformed cells, several mos-specific fragments were detected in addition to the 15-kilobase (kb) c-mos-bearing fragment: in MSV.B cells, originally transformed by the ancestral MoMuSV, the v-mos sequences were found migrating with 23-and 10.5-kb fragments; whereas in MT cells, transformed by the clonal m3MoMuSV, they were located at 21 and 12 kb (Fig. 1A, lanes 2 and 4) . An increased number of v-mos-specific fragments was found in EcoRI digests of MSVIF DNA, at 23, 12, 10.5, 9.4, 8.0, and 7.5 kb (Fig. lA,  lane 3) . Hybridization with HindIII digests revealed that the v-mos sequence was located in a 1.6-kb fragment from both MSV.B and MSVIF cells. However, the signal was clearly more abundant in MSVIF as compared to MSV.B DNA. Similarly, digestion with Sac I disclosed a significant signal enhancement of a 5.4-kb fragment in the DNA of MSVIF cells that appeared to be at least twice as strong as the signal in MSV.B or MT cells (Fig. 2 A and B ). 
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In Xba I digests, a 2.8-kb c-mos and a 1. (Fig. 3A, lane 3) , while only the signal obtained with the MuLV long terminal repeat probe was detected in the RNA extracted from virions released into the culture medium (Fig. 3B, lanes 3 and 4) . These results suggest that, in MSVIF cells, the transcribed MoMuSV genome was not encapsidated into mature virions.
Lack of Tumorigenicity of MSVIF Cells in Nude Mice. The extent to which the IFN-induced phenotypic reversion of MSVIF cells modified their malignant character in spite of the persistence of the mos oncogene was explored. The results are shown in Table 3 2, and 3 , respectively). Five microgram amounts were electrophoresed for 4 hr at 6 V/cm on a 1% agarose gel (33) . After blotting onto nitrocellulose sheets (33) , mos-specific RNA was detected by hybridization at 420C to 5 x 106 cpm of nick-translated v-mos probe. HindIII-digested fragments of X phage DNA were electrophoresed in parallel. (B) Virus released in the medium was collected and purified (37) Restriction analysis revealed that: (i) in both reverted MSVIF and control MoMuSV-transformed cells, the mosspecific fragments are located in the same sized fragments indicating that no major genomic modification had occurred as a result of the IFN treatment; (ii) more copies of the v-mos sequence were found in revertant MSVIF relative to control MoMuSV-transformed DNA. Multiple insertion sites were detected in an EcoRI digest of MSVIF DNA, whereas analysis of HindIII and Sac I digests confirmed the integrity of MoMuSV proviral sequences. Moreover, the mos-specific signal was more abundant in MSVIF DNA, indicating at least twice as many copies of the gene as in control MoMuSVtransformed cells. The intensely labeled 1.6-kb fragment seen in HindIII digests reveals an internal cleavage site in the viral genome characteristic of the ancestral MoMuSV strains (38, 40) .
These results aid in the identification of the reverted, nonmalignant MSVIF cell line as a derivative of MoMuSVtransformed, malignant cells. The presence of mos-specific transcripts in the nonmalignant MSVIF cells is surprising. Furthermore, while functionally unmodified helper virions were released from the reverted cells, mos-containing particles were missing. This latter result could be attributed to a posttranscriptional block. IFN may be involved in the impaired sarcoma virus formation (13), but additional investigation will be required to understand the stability of this reversion in the absence of IFN.
The absence of transforming virions could result from mutational events in reverted MoMuSV-transformed cells in which the viral genome, either lost or defective, can no longer be rescued (41) (42) (43) (44) . However, the presence of mos-specific fragments in the reverted MSVIF line indicate that the viral genome has not been lost. The biological properties of the malignant and the IFN-reverted nonmalignant cells are summarized in Table 4 .
Different authors have also reported IFN-induced reversion from oncogenic to nonmalignant phenotypes (45, 46 
